Equity · Healthcare

SNSE

Sensei Biotherapeutics Inc · NGM

Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for SNSE to draw a line in its place.

The chart above plots the price of SNSE over the range selected — one day to the full history — drawn by TradingView from their own data.

SNSE insider trades

SEC Form 4

SNSE has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 1 June 2026.

Date Insider Type Shares Value

01 Jun 2026 Cambrian BioPharma Inc 10% Owner Sell 25,000 $501K

01 Jun 2026 Peyer James 10% Owner Sell 25,000 $501K

09 Dec 2025 Cambrian BioPharma Inc Sell 6,612 $55K

09 Dec 2025 Peyer James Sell 3,507 $28K

08 Dec 2025 Peyer James Sell 3,105 $27K

05 Dec 2025 Cambrian BioPharma Inc Sell 16,295 $187K

05 Dec 2025 Peyer James Sell 16,295 $187K

04 Dec 2025 Cambrian BioPharma Inc Sell 5,000 $45K

04 Dec 2025 Peyer James Sell 5,000 $45K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value

09 Dec 2025 Cambrian BioPharma Inc Option exercise 395 $3K

09 Dec 2025 Peyer James Option exercise 395 $3K

SNSE earnings

SEC EDGAR

Date Period EPS Revenue

31 Mar 2026 Q1 2026 $-131.45 —

31 Dec 2025 FY 2025 $-16.72 —

30 Sep 2025 Q3 2025 $-3.62 —

30 Jun 2025 Q2 2025 $-3.91 —

31 Mar 2025 Q1 2025 $-5.45 —

31 Dec 2024 FY 2024 $-24.01 —

30 Sep 2024 Q3 2024 $-5.77 —

30 Jun 2024 Q2 2024 $-5.69 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

SNSE insider trades

SNSE earnings

SNSE institutional holders